India Drug-Pricing Agency Tries New Tactic To Collect Overcharges
This article was originally published in PharmAsia News
Executive Summary
India's drug-pricing authority has stepped up its efforts to get pharmaceuticals to pay the fines assessed them for charging too much. The National Pharmaceutical Pricing Authority is developing new guidelines that allow local government authorities to collect fines from drug makers in the areas where they actually have assets. The practice has been to refer cases to district authorities on a case-by-case basis, but the new NPPA guidelines strengthen the government's ability to collect the assessments. The NPPA already has used the new method to collect on overcharges in five cases. (Click here for more